Literature DB >> 3923030

Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma.

R J Lutfi, M Fridmanis, A L Misiunas, O Pafume, E A Gonzalez, J A Villemur, M A Mazzini, H Niepomniszcze.   

Abstract

Melasma is localized hyperpigmentation over the forehead, upper lips, cheeks, and chin. In this study, evidence suggesting an association between autoimmune thyroid disorders and melasma and the relationship of thyroid disorders to the origin of melasma is presented. A total of 108 nonpregnant women, aged 20-56 yr, were divided into 2 groups for the purpose of this study: 1) melasma, 84 patients; 2) control group, 24 patients from the Dermatology Clinic matched for age and sex. Microsomal thyroid autoantibodies (MCHA) were sought in all subjects. TRH-TSH tests were performed in patients with melasma and in those women with goiter and/or positive MCHA tests from the control group. Studies were completed with serum T4, T3, and antithyroglobulin antibody (TGHA) measurements in all patients with thyroid abnormalities. In patients with melasma, the frequency of thyroid disorders (58.3%) was 4 times greater than in the control group. The MCHA-negative patients had 1) simple goiter (13.1%), 2) Plummer's disease (2.4%), and 3) TSH hyperresponse to TRH in nongoitrous patients (10.7%). Patients with positive MCHA tests (32.1%) were divided into 2 subgroups. One comprised those women with an apparently normal thyroid gland and thyroid function (n = 7), while the other included all patients with goiter and/or subclinical hypothyroidism (n = 20). Regarding the origin of the melasma, it was found that 70% of women who developed melasma during pregnancy or while using oral contraceptives had thyroid abnormalities compared to 39.4% of patients with idiopathic melasma. Subjects from the control group had a 12.5% incidence of thyroid abnormalities, and only 8.3% had positive MCHA. Estrogen, progesterone, or both could be the triggering factor in the development of melasma in women who have a particular predisposition toward both melasma and thyroid autoimmunity. Patients with idiopathic melasma had a lower frequency of thyroid abnormalities, suggesting that there may be different genetic patterns linked to autoimmune thyroid disease. We conclude that there is a true association between thyroid autoimmunity and melasma, mostly in women whose melasma develops during pregnancy or after ingestion of oral contraceptive drugs.

Entities:  

Keywords:  Autoimmune Response; Biology; Comparative Studies; Contraception; Contraceptive Methods--side effects; Corpus Luteum Hormones; Dermatological Effects; Estrogens; Family Planning; Hormones; Immunological Effects; Metabolic Effects; Oral Contraceptives--side effects; Physiology; Pregnancy; Progesterone; Reproduction; Reproductive Control Agents; Research Methodology; Studies

Mesh:

Substances:

Year:  1985        PMID: 3923030     DOI: 10.1210/jcem-61-1-28

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Melasma and laser treatment: an evidenced-based analysis.

Authors:  Shlomit Halachmi; Merete Haedersdal; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-06-14       Impact factor: 3.161

Review 2.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

Review 3.  Skin disorders and thyroid diseases.

Authors:  H Niepomniszcze; R H Amad
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

4.  The use of retinoic acid in association with microneedling in the treatment of epidermal melasma: efficacy and oxidative stress parameters.

Authors:  Clarissa L M da Silva Bergmann; Daniela Pochmann; Julio Bergmann; Fernanda Brasil Bocca; Isabel Proença; Jessica Marinho; Alexandre Mello; Caroline Dani
Journal:  Arch Dermatol Res       Date:  2020-09-25       Impact factor: 3.017

5.  Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients.

Authors:  Seray Külcü Çakmak; Nimet Özcan; Arzu Kılıç; Suha Koparal; Ferda Artüz; Atıl Çakmak; Kenan Köse
Journal:  Postepy Dermatol Alergol       Date:  2015-10-29       Impact factor: 1.837

Review 6.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 7.  Melasma update.

Authors:  Rashmi Sarkar; Pooja Arora; Vijay Kumar Garg; Sidharth Sonthalia; Narendra Gokhale
Journal:  Indian Dermatol Online J       Date:  2014-10

8.  Medical Management of Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group.

Authors:  Rashmi Sarkar; Narendra Gokhale; Kiran Godse; Pallavi Ailawadi; Latika Arya; Nilendu Sarma; R G Torsekar; V K Somani; Pooja Arora; Imran Majid; G Ravichandran; Mohan Singh; Sanjeev Aurangabadkar; Shehnaz Arsiwala; Sidharth Sonthalia; T Salim; Swapnil Shah
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

9.  Chemical peels for melasma in dark-skinned patients.

Authors:  Rashmi Sarkar; Shuchi Bansal; Vijay K Garg
Journal:  J Cutan Aesthet Surg       Date:  2012-10

10.  A clinical study of the cutaneous manifestations of hypothyroidism in kashmir valley.

Authors:  Mohammad Abid Keen; Iffat Hassan; Mohammad Hayat Bhat
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.